About this trial
The goal of this clinical trial is to test the MedMemos Intervention with parents and children who have received a bone marrow transplant. The main study questions are:
* Is the MedMemos intervention acceptable to patients and families? * Is the MedMemos intervention feasible for patients, families, and healthcare providers? * Does MedMemos help patients and families take their medications better?
Participants will be asked to complete surveys, attend 4 intervention sessions, and use an electronic box or pill bottle to store their medications in.
Eligibility criteria
Qualifiers
Child had a Pediatric Allogeneic Hematopoietic Cell Transplant (PAHCT)
Child is 0-12 years of age
At the time of recruitment child is still in the hospital for PAHCT
Child's primary caregiver is responsible for administering medical care and is willing to give consent to participate
Disqualifiers
Caregiver does not speak English, Spanish, or Arabic
Caregiver is not available to provide written permission for the child's participation
EMR or medical team report of the caregiver's cognitive status precludes completion of questionnaires
The child's medical status or condition precludes completion of the study questionnaires as determined by the physician or caregiver
Trial design
Treatments tested in this trial
- MedMemos